Citigroup’s Firefly Neuroscience AIFF Stock Holding History
Bought
Maintained
Sold
Other funds holding AIFF
M
BFM
CCA
Citigroup's AIFF Position: Q2 2026 in Review
Citigroup reduced its Firefly Neuroscience (AIFF) stake by 93% in Q2 2026, selling an estimated $46.3K and leaving 2,091 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #5365.
Citigroup first reported a position in AIFF in Q2 2025 and has held it in 4 quarters since. The position peaked at $62.5K in Q1 2026. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.
- Citigroup held 2,091 shares of Firefly Neuroscience worth $2.53K as of Q2 2026.
- Citigroup sold 26,572 Firefly Neuroscience shares in Q2 2026, an estimated $46.3K.
- Firefly Neuroscience made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5365 holding.
- Citigroup first reported a position in Firefly Neuroscience in Q2 2025 and has held it in 4 quarters since.
- Citigroup's Firefly Neuroscience position peaked at $62.5K in Q1 2026.
- 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.